3Burkhardt O, Welte T. 10 year's experience with the pneumococcal quinolone moxifloxacin. Expert Rev Anti Infect Ther. 2009, 7:645-668.
4Odenhoh I, Cars O. Pharmacodynamics of moxifloxacin and levofloxacin against streptococcus pneumoniae, staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli : simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model. J Antimicrob Chemother, 2006,58:960-965.
